08.04.2026 02:14
**Avalanche (AVAX) Nears $9.50 Target Amid Recent Pullback**
Sky‑high optimism surrounds Avalanche’s price trajectory as analysts converge on a $9.50 target within the next week, even though the token has slipped 8 % over the past 24 hours. Technical charts reveal a modest dip to $8.62, with the market probing the lower Bollinger Band near $8.41. The Relative Strength Index hovers around 40.9, suggesting that selling pressure may be exhausted and an oversold rebound could be imminent.
Looking ahead, the short‑term outlook predicts a rally toward $9.50 if buying interest resurges. Medium‑term forecasts broaden the horizon to a $8.80‑$10.00 band for the ensuing month, with a decisive bullish breakout anticipated at $9.77 and a sturdy floor of support set at $8.25.
Industry voices add nuance to the narrative. CoinMarketCap’s AI commentary on April 5 underscores that “AVAX’s path forward hinges on institutional adoption clashing with fierce competition and shaky retail sentiment,” flagging institutional demand as the catalyst for sustained growth. Meanwhile, Coinpedia’s April 4 outlook paints a more aggressive picture, asserting that “if demand returns in April, the first half of the year could see a recovery rally toward $20, with an ambitious secondary target at $28.” BanklessTimes echoed this cautious optimism on April 6, noting that “AVAX gained 6.7 % on Monday morning, outpacing Bitcoin’s 3.2 % rise,” and identifying $9.50 as the pivotal inflection point that could propel the price toward $10.
From a technical standpoint, the latest price action shows Avalanche trading at $8.62, a 8.10 % decline from the previous day, while testing the lower Bollinger Band at $8.41. Hourly candlestick patterns, derived from roughly 96 recent bars, reflect mixed signals, yet the RSI of 40.9 situates the asset in neutral territory, leaving room for a potential upside bounce.
In sum, while Avalanche presently rides a short‑term downtrend, the confluence of supportive technical levels, institutional interest, and bullish price targets suggests that a recovery toward $9.50—and possibly higher—may be just around the corner.
